Literature DB >> 3491166

Membrane-disruptive effect of human milk: inactivation of enveloped viruses.

C E Isaacs, H Thormar, T Pessolano.   

Abstract

Fresh human milk treated with antibody to secretory IgA had no effect on viral infectivity but became antiviral after 1 hr in the stomachs of suckling infants. Antiviral activity also appeared in fresh milk stored at 4 C for at least two days. The antiviral activity, which reduced titers of virus by as much as 10,000-fold, only affected enveloped viruses and was localized in the milk lipid fraction. Its appearance in stored milk was apparently due to fatty acids released by the activity of milk lipases, particularly lipoprotein lipase. Antiviral activity in the infants' stomach, however, most likely resulted from the activity of gastric and lingual lipases on milk triglycerides and caused the release of antiviral fatty acids. Milk and stomach contents that were antiviral also lysed cultured cells by disruption of their plasma membrane. Cell lysis was also caused by purified linoleic acid, which is a normal constituent of human milk triglycerides.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491166      PMCID: PMC7109787          DOI: 10.1093/infdis/154.6.966

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention.

Authors:  Lin Wang; Alexandra Beumer Sassi; Dorothy Patton; Charles Isaacs; B J Moncla; Phalguni Gupta; Lisa Cencia Rohan
Journal:  Drug Dev Ind Pharm       Date:  2011-12-10       Impact factor: 3.225

2.  Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides.

Authors:  H Thormar; C E Isaacs; H R Brown; M R Barshatzky; T Pessolano
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

3.  Antiviral and antibacterial lipids in human milk and infant formula feeds.

Authors:  C E Isaacs; S Kashyap; W C Heird; H Thormar
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

4.  Poliovirus antibody titres, relative affinity, and neutralising capacity in maternal milk.

Authors:  S Zaman; B Carlsson; A Morikawa; S Jeansson; I Narayanan; K Thiringer; F Jalil; L A Hanson
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

5.  Changes in Fatty Acid Composition of Human Milk in Response to Cold-Like Symptoms in the Lactating Mother and Infant.

Authors:  Andrew S Gardner; Ibrahim A Rahman; Ching T Lai; Anna Hepworth; Naomi Trengove; Peter E Hartmann; Donna T Geddes
Journal:  Nutrients       Date:  2017-09-19       Impact factor: 5.717

6.  Storage-Dependent Generation of Potent Anti-ZIKV Activity in Human Breast Milk.

Authors:  Carina Conzelmann; Min Zou; Rüdiger Groß; Mirja Harms; Annika Röcker; Christian U Riedel; Jan Münch; Janis A Müller
Journal:  Viruses       Date:  2019-06-28       Impact factor: 5.048

7.  Polyunsaturated Fatty Acid Composition in Breast Milk Plasma of HIV-infected and Uninfected Mothers in Relation to Infant Clinical Outcomes.

Authors:  Lucy Mabaya; Hilda Tendisa Matarira; Donald Moshen Tanyanyiwa; Cuthbert Musarurwa; Johannes Mukwembi; Taona Emmah Mudluli; Tatenda Marera
Journal:  Nutr Metab Insights       Date:  2022-02-07

Review 8.  Antimicrobial Tear Lipids in the Ocular Surface Defense.

Authors:  Poonam Mudgil
Journal:  Front Cell Infect Microbiol       Date:  2022-03-31       Impact factor: 6.073

Review 9.  Recently described innate broad spectrum virus inhibitors.

Authors:  S Baron; D Niesel; I P Singh; L McKerlie; J Poast; A Chopra; G Antonelli; F Dianzani; D H Coppenhaver
Journal:  Microb Pathog       Date:  1989-10       Impact factor: 3.738

Review 10.  Mother-to-Child Transmission of Arboviruses during Breastfeeding: From Epidemiology to Cellular Mechanisms.

Authors:  Sophie Desgraupes; Mathieu Hubert; Antoine Gessain; Pierre-Emmanuel Ceccaldi; Aurore Vidy
Journal:  Viruses       Date:  2021-07-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.